KIT and gastrointestinal stromal tumor: Debiec-Rychter Debiec-Rychter M M Sciot Sciot R R Le Cesne Le Cesne A A KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Eur J Cancer Eur J Cancer 2006 2006 42 42 1093 1093 1103 1103 10.1016/j.ejca.2006.01.030 10.1016/j.ejca.2006.01.030 supplied-pmid 16624552?